AKBLF (Alk-Abello AS) Cyclically Adjusted Book per Share: $3.38 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AKBLF Alk-Abello AS AKBLF
93 GF Score
Price $37.92
GF Value $39.09
Valuation Fairly Valued
View Full Analysis

What is Alk-Abello AS Cyclically Adjusted Book per Share?

Alk-Abello AS AKBLF 93 Cyclically Adjusted Book per Share is $3.38 as of Jun. 2026. GuruFocus rates AKBLF with a GF Score™ of 93/100 and a GF Value™ of $39.09 (Fairly Valued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Alk-Abello AS's adjusted book value per share for the three months ended in Jun. 2026 was $4.827. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.38 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Alk-Abello AS's average Cyclically Adjusted Book Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Alk-Abello AS was 7.70% per year. The lowest was 1.30% per year. And the median was 6.75% per year.

As of today (2026-08-21), Alk-Abello AS's current stock price is $37.915. Alk-Abello AS's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $3.38. Alk-Abello AS's Cyclically Adjusted PB Ratio of today is 11.22.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Alk-Abello AS was 13.68. The lowest was 2.65. And the median was 7.73.


Alk-Abello AS  (OTCPK:AKBLF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Alk-Abello AS's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=37.915/3.38
=11.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Alk-Abello AS was 13.68. The lowest was 2.65. And the median was 7.73.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Alk-Abello AS Cyclically Adjusted Book per Share Related Terms


Alk-Abello AS Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Cyclically Adjusted Book per Share Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 2.33 2.19 2.51 3.06

Alk-Abello AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 2.66 3.06 3.06 3.38

AKBLF vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Alk-Abello AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello AS Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's Cyclically Adjusted PB Ratio falls into.


AKBLF
93GF Score
Alk-Abello AS AKBLF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alk-Abello AS's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.827/122.9700*122.9700
=4.827

Current CPI (Jun. 2026) = 122.9700.

Alk-Abello AS Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.174 100.200 2.668
201612 2.073 100.300 2.542
201703 2.064 101.200 2.508
201706 2.140 101.200 2.600
201709 2.242 101.800 2.708
201712 2.430 101.300 2.950
201803 2.528 101.700 3.057
201806 2.386 102.300 2.868
201809 2.352 102.400 2.824
201812 2.247 102.100 2.706
201903 2.293 102.900 2.740
201906 2.206 102.900 2.636
201909 2.163 102.900 2.585
201912 2.167 102.900 2.590
202003 2.220 103.300 2.643
202006 2.243 103.200 2.673
202009 2.323 103.500 2.760
202012 2.359 103.400 2.805
202103 2.423 104.300 2.857
202106 2.398 105.000 2.808
202109 2.388 105.800 2.776
202112 2.405 106.600 2.774
202203 2.459 109.900 2.751
202206 2.442 113.600 2.643
202209 2.377 116.400 2.511
202212 2.570 115.900 2.727
202303 2.680 117.300 2.810
202306 2.753 116.400 2.908
202309 2.809 117.400 2.942
202312 2.942 116.700 3.100
202403 3.089 118.400 3.208
202406 3.205 118.500 3.326
202409 3.420 118.900 3.537
202412 3.407 118.900 3.524
202503 3.716 120.200 3.802
202506 4.080 120.700 4.157
202509 4.381 121.600 4.430
202512 4.561 121.200 4.628
202603 4.585 121.680 4.634
202606 4.827 122.970 4.827

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $3.38 mean?
Alk-Abello AS (AKBLF) has a Cyclically Adjusted Book per Share of $3.38 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Alk-Abello AS and its competitors.
Is Alk-Abello AS's Cyclically Adjusted Book per Share too high?
Alk-Abello AS's current Cyclically Adjusted Book per Share is $3.38. Overall, Alk-Abello AS has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Alk-Abello AS's Cyclically Adjusted Book per Share of $3.38 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Cyclically Adjusted Book per Share is $3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (AKBLF) is currently considered Fairly Valued. The stock's GF Value™ is $39.09, compared to a current price of $37.92 — trading 3% below its estimated fair value. The current Cyclically Adjusted Book per Share is $3.38. Alk-Abello AS's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Alk-Abello AS (AKBLF), the current Cyclically Adjusted Book per Share is $3.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (AKBLF) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be undervalued. The current stock price of $37.92 is trading 3% below its estimated GF Value™ of $39.09. GuruFocus considers Alk-Abello AS to be Fairly Valued.

Key valuation signals for AKBLF:

  • Cyclically Adjusted Book per Share: $3.38
  • GF Value™: $39.09 vs. price of $37.92 (3% below fair value)
  • GF Score™: 93/100

No single metric tells the full story. See the AKBLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
93GF Score

Get the complete analysis for AKBLF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.92
Price
$39.09
GF Value